CombiMatrix Awarded $32.1M in Suit Against Insurer; Will Use Cash to Grow Dx Business | GenomeWeb
After a year spent rolling out new diagnostic products on a quarterly basis while at the same time looking to reduce its operating expenses, CombiMatrix may soon be swimming in cash.
 
The firm announced last week that the US District Court for the Central District of California awarded it $32.1 million in its lawsuit against National Union Fire Ins. Co., a Pittsburgh-based insurance company.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.